Literature DB >> 24051693

Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.

Jingmei Lin1, Noah C Welker2, Zijin Zhao1, Yong Li1, Jianjun Zhang3, Sarah A Reuss1, Xinjun Zhang4, Hwajeong Lee5, Yunlong Liu4, Mary P Bronner2.   

Abstract

The diagnosis of idiopathic inflammatory bowel disease can be challenging. MicroRNAs (miRNAs) are small, non-coding RNAs that regulate protein synthesis through post-transcriptional suppression. This study is to identify new miRNA markers in inflammatory bowel disease, and to examine whether miRNA biomarkers might assist in the diagnosis of inflammatory bowel disease. Illumina small RNA sequencing was performed on non-dysplastic fresh-frozen colonic mucosa samples of the distalmost colectomy tissue from 19 patients with inflammatory bowel disease (10 ulcerative colitis and 9 Crohn disease) and 18 patients with diverticular disease serving as controls. To determine differentially expressed miRNAs, the USeq software package identified 44 miRNAs with altered expression (fold change ≥ 2 and false discovery rate ≤ 0.10) compared with the controls. Among them, a panel of nine miRNAs was aberrantly expressed in both ulcerative colitis and Crohn disease. Validation assays performed using quantitative reverse transcription PCR (qRT-PCR) on additional frozen tissue from ulcerative colitis, Crohn disease, and control groups confirmed specific differential expression in inflammatory bowel disease for miR-31, miR-206, miR-424, and miR-146a (P<0.05). The expression of these four miRNAs was further evaluated on formalin-fixed, paraffin-embedded tissue of the distalmost colectomy mucosa from cohorts of diverticular disease controls (n=29), ulcerative colitis (n=36), Crohn disease (n=26), and the other diseases mimicking inflammatory bowel disease including infectious colitis (n=12) and chronic ischemic colitis (n=19), again confirming increased expression specific to inflammatory bowel disease (P<0.05). In summary, we demonstrate that miR-31, miR-206, miR-424, and miR-146a are novel specific biomarkers of inflammatory bowel disease. Furthermore, miR-31 is universally expressed in both ulcerative colitis and Crohn disease not only in fresh-frozen but also in formalin-fixed, paraffin-embedded tissues.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24051693     DOI: 10.1038/modpathol.2013.152

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  39 in total

Review 1.  Role of MiRNAs in Inflammatory Bowel Disease.

Authors:  Bo Cao; Xin Zhou; Jiaojiao Ma; Wei Zhou; Wanli Yang; Daiming Fan; Liu Hong
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

Review 2.  miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.

Authors:  Xiao-Min Xu; Hong-Jie Zhang
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.

Authors:  Adam M Zahm; Nicholas J Hand; Daphne M Tsoucas; Claire L Le Guen; Robert N Baldassano; Joshua R Friedman
Journal:  J Crohns Colitis       Date:  2014-03-07       Impact factor: 9.071

Review 4.  Extracellular vesicles regulate immune responses and cellular function in intestinal inflammation and repair.

Authors:  Triet M Bui; Lorraine A Mascarenhas; Ronen Sumagin
Journal:  Tissue Barriers       Date:  2018-02-09

Review 5.  miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?

Authors:  A K M Nawshad Hossian; Gerardo G Mackenzie; George Mattheolabakis
Journal:  Nanomedicine (Lond)       Date:  2019-11-18       Impact factor: 5.307

6.  Fascin protein stabilization by miR-146a implicated in the process of a chronic inflammation-related colon carcinogenesis model.

Authors:  Yusuke Kanda; Tokuichi Kawaguchi; Mitsuhiko Osaki; Kunishige Onuma; Takahiro Ochiya; Tomoyuki Kitagawa; Futoshi Okada
Journal:  Inflamm Res       Date:  2018-07-28       Impact factor: 4.575

Review 7.  The emerging role of miRNAs in inflammatory bowel disease: a review.

Authors:  Christopher G Chapman; Joel Pekow
Journal:  Therap Adv Gastroenterol       Date:  2015-01       Impact factor: 4.409

8.  Colonic epithelial miR-31 associates with the development of Crohn's phenotypes.

Authors:  Benjamin P Keith; Jasmine B Barrow; Takahiko Toyonaga; Nevzat Kazgan; Michelle Hoffner O'Connor; Neil D Shah; Matthew S Schaner; Elisabeth A Wolber; Omar K Trad; Greg R Gipson; Wendy A Pitman; Matthew Kanke; Shruti J Saxena; Nicole Chaumont; Timothy S Sadiq; Mark J Koruda; Paul A Cotney; Nancy Allbritton; Dimitri G Trembath; Francisco Sylvester; Terrence S Furey; Praveen Sethupathy; Shehzad Z Sheikh
Journal:  JCI Insight       Date:  2018-10-04

Review 9.  MicroRNAs: how many in inflammatory bowel disease?

Authors:  Jeremy S Schaefer
Journal:  Curr Opin Gastroenterol       Date:  2016-07       Impact factor: 3.287

Review 10.  MicroRNA in inflammatory bowel disease: Translational research and clinical implication.

Authors:  Kurt Fisher; Jingmei Lin
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.